company background image
TFX logo

Teleflex NYSE:TFX Stock Report

Last Price

US$129.48

Market Cap

US$5.7b

7D

0.3%

1Y

-37.6%

Updated

17 Apr, 2025

Data

Company Financials +

Teleflex Incorporated

NYSE:TFX Stock Report

Market Cap: US$5.7b

TFX Stock Overview

Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. More details

TFX fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance0/6
Financial Health5/6
Dividends2/6

Rewards

Trading at 62.2% below our estimate of its fair value

Earnings are forecast to grow 25.39% per year

Analysts in good agreement that stock price will rise by 25%

Risk Analysis

Large one-off items impacting financial results

Profit margins (2.3%) are lower than last year (12%)


Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

TFX logo
Teleflex
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts

Biotronik Acquisition And Company Separation Will Expand Vascular Intervention Portfolio

Key Takeaways The acquisition of Biotronik's Vascular Intervention business and the separation into two companies aim to drive growth and enhance margins. Focused capital allocation and R&D investment in interventional products are set to boost innovation and shareholder value.
View narrative
US$161.82
FV
20.0% undervalued intrinsic discount
2.49%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
2 days ago author updated this narrative
View Teleflex Community

Teleflex Incorporated Competitors

Integer Holdings

NYSE:ITGR

US$4.1b

Hologic

NasdaqGS:HOLX

US$12.7b

Inspire Medical Systems

NYSE:INSP

US$4.4b

Zimmer Biomet Holdings

NYSE:ZBH

US$19.3b

Price History & Performance

Summary of share price highs, lows and changes for Teleflex
Historical stock prices
Current Share PriceUS$129.48
52 Week HighUS$249.91
52 Week LowUS$124.66
Beta1.19
1 Month Change-7.49%
3 Month Change-28.57%
1 Year Change-37.56%
3 Year Change-61.75%
5 Year Change-61.28%
Change since IPO34,461.92%

Recent News & Updates

Why Investors Shouldn't Be Surprised By Teleflex Incorporated's (NYSE:TFX) Low P/S

Mar 31
Why Investors Shouldn't Be Surprised By Teleflex Incorporated's (NYSE:TFX) Low P/S

Recent updates

Why Investors Shouldn't Be Surprised By Teleflex Incorporated's (NYSE:TFX) Low P/S

Mar 31
Why Investors Shouldn't Be Surprised By Teleflex Incorporated's (NYSE:TFX) Low P/S

Teleflex's (NYSE:TFX) Conservative Accounting Might Explain Soft Earnings

Mar 09
Teleflex's (NYSE:TFX) Conservative Accounting Might Explain Soft Earnings

Teleflex's Bold Transformation: Why I'm Skeptical On Value Creation

Mar 02

Be Wary Of Teleflex (NYSE:TFX) And Its Returns On Capital

Feb 03
Be Wary Of Teleflex (NYSE:TFX) And Its Returns On Capital

Is Teleflex (NYSE:TFX) Using Too Much Debt?

Jan 14
Is Teleflex (NYSE:TFX) Using Too Much Debt?

Should You Think About Buying Teleflex Incorporated (NYSE:TFX) Now?

Dec 27
Should You Think About Buying Teleflex Incorporated (NYSE:TFX) Now?

Teleflex Incorporated: Compelling Only On One Metric

Dec 11

Why We're Not Concerned About Teleflex Incorporated's (NYSE:TFX) Share Price

Dec 09
Why We're Not Concerned About Teleflex Incorporated's (NYSE:TFX) Share Price

Here's What Analysts Are Forecasting For Teleflex Incorporated (NYSE:TFX) After Its Third-Quarter Results

Nov 02
Here's What Analysts Are Forecasting For Teleflex Incorporated (NYSE:TFX) After Its Third-Quarter Results

Does Teleflex (NYSE:TFX) Have A Healthy Balance Sheet?

Sep 30
Does Teleflex (NYSE:TFX) Have A Healthy Balance Sheet?

Returns On Capital At Teleflex (NYSE:TFX) Paint A Concerning Picture

Sep 14
Returns On Capital At Teleflex (NYSE:TFX) Paint A Concerning Picture

Market Participants Recognise Teleflex Incorporated's (NYSE:TFX) Earnings

Aug 29
Market Participants Recognise Teleflex Incorporated's (NYSE:TFX) Earnings

Teleflex Reinvesting In Growth, But Valuation Isn't That Compelling

Aug 26
author-image

Innovation And Critical Acquisitions Propel Revenue Recovery

Aug 22 Expansion in geographic markets and new product introductions suggest ongoing innovation and revenue growth opportunities.

Is Teleflex Incorporated (NYSE:TFX) Potentially Undervalued?

Jul 29
Is Teleflex Incorporated (NYSE:TFX) Potentially Undervalued?

Here's Why Teleflex (NYSE:TFX) Can Manage Its Debt Responsibly

Jun 20
Here's Why Teleflex (NYSE:TFX) Can Manage Its Debt Responsibly

Investors Could Be Concerned With Teleflex's (NYSE:TFX) Returns On Capital

Jun 05
Investors Could Be Concerned With Teleflex's (NYSE:TFX) Returns On Capital

Is Teleflex Incorporated (NYSE:TFX) Trading At A 39% Discount?

May 21
Is Teleflex Incorporated (NYSE:TFX) Trading At A 39% Discount?

Teleflex: Compelling, Despite Some Operational Hiccups

May 06

What Is Teleflex Incorporated's (NYSE:TFX) Share Price Doing?

Apr 21
What Is Teleflex Incorporated's (NYSE:TFX) Share Price Doing?

Teleflex Shares Hit Hard As Growth Concerns Stack Up

Oct 13

Teleflex: Flexing Its Muscles A Bit

Jul 27

Shareholder Returns

TFXUS Medical EquipmentUS Market
7D0.3%1.6%-0.05%
1Y-37.6%4.5%5.7%

Return vs Industry: TFX underperformed the US Medical Equipment industry which returned 3.2% over the past year.

Return vs Market: TFX underperformed the US Market which returned 4.6% over the past year.

Price Volatility

Is TFX's price volatile compared to industry and market?
TFX volatility
TFX Average Weekly Movement7.4%
Medical Equipment Industry Average Movement9.0%
Market Average Movement7.7%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market4.1%

Stable Share Price: TFX has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: TFX's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194314,100Liam Kellywww.teleflex.com

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.

Teleflex Incorporated Fundamentals Summary

How do Teleflex's earnings and revenue compare to its market cap?
TFX fundamental statistics
Market capUS$5.73b
Earnings (TTM)US$70.16m
Revenue (TTM)US$3.05b

82.5x

P/E Ratio

1.9x

P/S Ratio

Is TFX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TFX income statement (TTM)
RevenueUS$3.05b
Cost of RevenueUS$1.34b
Gross ProfitUS$1.71b
Other ExpensesUS$1.64b
EarningsUS$70.16m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

May 01, 2025

Earnings per share (EPS)1.57
Gross Margin56.18%
Net Profit Margin2.30%
Debt/Equity Ratio38.7%

How did TFX perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

91%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/17 13:00
End of Day Share Price 2025/04/17 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Teleflex Incorporated is covered by 35 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Matthew TaylorBarclays
Craig BijouBofA Global Research